Page last updated: 2024-12-08

lamotrigine 2-n-glucuronide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

lamotrigine 2-N-glucuronide: structure given in first source; major metabolite of lamotrigine [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID164342
MeSH IDM0200557

Synonyms (14)

Synonym
lamotrigine 2-n-glucuronide
133310-19-7
lamotrigine n2-glucuronide 85%
(2s,3s,4s,5r,6r)-6-[3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazin-2-ium-2-yl]-3,4,5-trihydroxyoxane-2-carboxylic acid
1,2,4-triazinium, 3,5-diamino-6-(2,3-dichlorophenyl)-2-beta-d-glucopyranuronosyl-
135288-68-5
lamotrigine n2-glucuronide
unii-xo321mnh5m
xo321mnh5m ,
DTXSID80158073
lamotrigine-2-n-glucuronide
Q27293926
n-2-beta-d-glucuronide
lamotrigine n-2- beta -d-glucuronide

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
"This study aimed to develop a population pharmacokinetic model for quantitative evaluation of the influence of genetic variants in metabolic enzymes and transporters on lamotrigine pharmacokinetics while taking into account the influence of various clinical, biochemical and demographic factors."( Pharmacokinetics of lamotrigine and its metabolite N-2-glucuronide: Influence of polymorphism of UDP-glucuronosyltransferases and drug transporters.
Dolžan, V; Grabnar, I; Kastelic, M; Lorber, B; Milosheska, D; Vovk, T, 2016
)
0.43
" Population pharmacokinetic analysis was performed by non-linear mixed effects modelling."( Pharmacokinetics of lamotrigine and its metabolite N-2-glucuronide: Influence of polymorphism of UDP-glucuronosyltransferases and drug transporters.
Dolžan, V; Grabnar, I; Kastelic, M; Lorber, B; Milosheska, D; Vovk, T, 2016
)
0.43

Dosage Studied

ExcerptRelevanceReference
"We included 100 patients with epilepsy on stable dosing with lamotrigine as mono or adjunctive therapy."( Pharmacokinetics of lamotrigine and its metabolite N-2-glucuronide: Influence of polymorphism of UDP-glucuronosyltransferases and drug transporters.
Dolžan, V; Grabnar, I; Kastelic, M; Lorber, B; Milosheska, D; Vovk, T, 2016
)
0.43
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (12.50)18.2507
2000's3 (37.50)29.6817
2010's4 (50.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.56

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.56 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.86 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.56)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (12.50%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (87.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]